Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Medical Oncology
ctDNA
Questions discussed in this category
How do you approach early-stage breast cancer patients who are asking for ctDNA or tumor marker surveillance (or previously receiving these with another provider) when these are not part of the NCCN or ASCO guidelines?
2 Answers available
How would positive ctDNA results after 12 cycles of adjuvant FOLFOX affect your management for patients with colon cancer?
4 Answers available
22020
13370
Papers discussed in this category
N Engl J Med, 2022 Jun 04
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.
JCO precision oncology, 2022 Jul
Reply to F. Dayyani et al.
Related Topics in Medical Oncology
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Oncology
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers